Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy
- PMID: 20089283
- DOI: 10.1016/j.juro.2009.11.043
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy
Abstract
Purpose: Transrectal ultrasound guided prostate biopsy is widely used to confirm the diagnosis of prostate cancer. The technique has been associated with significant morbidity in a small proportion of patients.
Materials and methods: We conducted a population based study of 75,190 men who underwent a transrectal ultrasound guided biopsy in Ontario, Canada, between 1996 and 2005. We used hospital and cancer registry administrative databases to estimate the rates of hospital admission and mortality due to urological complications associated with the procedure.
Results: Of the 75,190 men who underwent transrectal ultrasound biopsy 33,508 (44.6%) were diagnosed with prostate cancer and 41,682 (55.4%) did not have prostate cancer. The hospital admission rate for urological complications within 30 days of the procedure for men without cancer was 1.9% (781/41,482). The 30-day hospital admission rate increased from 1.0% in 1996 to 4.1% in 2005 (p for trend <0.0001). The majority of hospital admissions (72%) were for infection related reasons. The probability of being admitted to hospital within 30 days of having the procedure increased 4-fold between 1996 and 2005 (OR 3.7, 95% CI 2.0-7.0, p <0.0001). The overall 30-day mortality rate was 0.09% but did not change during the study period.
Conclusions: The hospital admission rates for complications following transrectal ultrasound guided prostate biopsy have increased dramatically during the last 10 years primarily due to an increasing rate of infection related complications.
2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Prostate biopsy: a risk-benefit analysis.J Urol. 2010 Mar;183(3):852-3. doi: 10.1016/j.juro.2009.12.063. Epub 2010 Jan 20. J Urol. 2010. PMID: 20089273 No abstract available.
-
Editorial comment.J Urol. 2010 Mar;183(3):969. doi: 10.1016/j.juro.2009.11.118. Epub 2010 Jan 20. J Urol. 2010. PMID: 20089275 No abstract available.
-
Editorial comment.J Urol. 2010 Mar;183(3):968-9. doi: 10.1016/j.juro.2009.11.117. Epub 2010 Jan 20. J Urol. 2010. PMID: 20089282 No abstract available.
-
Re: increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy: R. K. Nam, R. Saskin, Y. Lee, Y. Liu, C. Law, L. H. Klotz, D. A. Loblaw, J. Trachtenberg, A. Stanimirovic, A. E. Simor, A. Seth, D. R. Urbach and S. A. Narod J Urol 2010; 183: 963-969.J Urol. 2010 Nov;184(5):2216-7; author reply 2217. doi: 10.1016/j.juro.2010.06.121. Epub 2010 Sep 22. J Urol. 2010. PMID: 20864132 No abstract available.
Similar articles
-
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.J Urol. 2013 Jan;189(1 Suppl):S12-7; discussion S17-8. doi: 10.1016/j.juro.2012.11.015. J Urol. 2013. PMID: 23234616
-
Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England.Int J Urol. 2015 Feb;22(2):181-6. doi: 10.1111/iju.12634. Epub 2014 Sep 26. Int J Urol. 2015. PMID: 25257575
-
[Complications of prostatic echo-guided transrectal biopsy and tolerance depending on the patient and the operator. Study of 205 patients].Arch Esp Urol. 2002 Jun;55(5):509-21. Arch Esp Urol. 2002. PMID: 12174417 Spanish.
-
[Complications of multiple transrectal ultrasound-guided biopsy of the prostate].Arch Ital Urol Androl. 2000 Dec;72(4):249-53. Arch Ital Urol Androl. 2000. PMID: 11221048 Review. Italian.
-
Prevention and treatment of biopsy-related complications.Curr Urol Rep. 2014 Feb;15(2):381. doi: 10.1007/s11934-013-0381-2. Curr Urol Rep. 2014. PMID: 24384997 Review.
Cited by
-
Rapid Near-Patient Impedimetric Sensing Platform for Prostate Cancer Diagnosis.ACS Omega. 2024 Mar 15;9(12):14580-14591. doi: 10.1021/acsomega.4c00843. eCollection 2024 Mar 26. ACS Omega. 2024. PMID: 38560003 Free PMC article.
-
Shifting to transperineal prostate biopsy: A narrative review.Prostate Int. 2024 Mar;12(1):10-14. doi: 10.1016/j.prnil.2023.11.003. Epub 2023 Nov 30. Prostate Int. 2024. PMID: 38523899 Free PMC article. Review.
-
Targeted augmented reality-guided transperineal prostate biopsies study: initial experience.Ther Adv Urol. 2024 Mar 8;16:17562872241232582. doi: 10.1177/17562872241232582. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 38464882 Free PMC article.
-
A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer.PLoS One. 2024 Feb 8;19(2):e0285745. doi: 10.1371/journal.pone.0285745. eCollection 2024. PLoS One. 2024. PMID: 38329970 Free PMC article.
-
Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.JAMA Netw Open. 2023 Nov 1;6(11):e2344856. doi: 10.1001/jamanetworkopen.2023.44856. JAMA Netw Open. 2023. PMID: 38019516 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources